Cite

HARVARD Citation

    Garcia, I. et al. (n.d.). 22P Early changes in plasma cell-free DNA (cfDNA) as a predictive biomarker of immune checkpoint inhibitors (ICIs) efficacy. Annals of oncology. p. . [Online]. 
  
Back to record